The ARYx mission is to make proven therapies safer. By applying its retrometabolic approach to pharmaceutical discovery and development, ARYx intends to serve patients by fundamentally improving the safety of oral therapies in large, chronic markets while maintaining their efficacy. To optimize shareholder value, ARYx's goal is to be a profitable company with a continuing pipeline of products, balancing risk against rewards through collaborations with pharmaceutical partners.

ARYx Values

• High ethical standards
• Creativity leading to innovation
• Mutual trust
• Passionate curiosity
• Respect for importance of goals and timelines
• Teamwork
• Open communications
• Knowledge
• Continuous improvement